Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens

Molecular Biology of the Cell

Volumn 23, Issue 4, 2012, Pages 533-542

  Ivkovic, Sanja ^a   Beadle, Christopher ^a   Noticewala, Sonal ^b   Massey, Susan C ^c   Swanson, Kristin R ^c   Toro, Laura N ^d   Bresnick, Anne R ^d   Canoll, Peter ^b   Rosenfeld, Steven S ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; BLEBBISTATIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; IMATINIB; JASPAMIDE; LATRUNCULIN A; LATRUNCULIN B; LY 27632; MYOSIN HEAVY CHAIN; MYOSIN II; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; RHO KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN SLICE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; NEURAL STEM CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; NONMUSCLE MYOSIN TYPE IIA; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84857198896     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-01-0039     Document Type: Article

References (57)

1. Angers-Loustau A, Hering R, Werbowetski TE, Kaplan DR, Del Maestro RF (2004). Src regulates actin dynamics and invasion of malignant glial cells in three dimensions. Mol Cancer Res 2, 595-605. (Pubitemid 39557663)
2. Assanah M, Lochhead R, Ogden A, Bruce J, Goldman J, Canoll P (2006). Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci 26, 6781-6790. (Pubitemid 44315239)
3. Assanah MC, Suzuki SO, Chen A, Bruce JN, Goldman JE, Canoll P (2009). PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain. Glia 57, 1835-1847.
4. Beadle C, Assanah MC, Monzo P, Vallee R, Rosenfeld SS, Canoll P (2008). The role of myosin II in glioma invasion of the brain. Mol Biol Cell 19, 3357-3368.
5. Ben-Ya'acov A, Ravid S (2003). Epidermal growth factor-mediated transient phosphorylation and membrane localization of myosin II-B are required for efficient chemotaxis. J Biol Chem 278, 40032-40040. (Pubitemid 37248569)
6. Buckner JC, O'Fallon JR, Dinapoli RP, Schomberg PJ, Farr G, Schaefer P, Giannini C, Scheithauer BW, Ballman KV (2007). Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade. J Neurooncol 84, 279-286. (Pubitemid 47108519)
7. Burger PC, Dubois PJ, Schold SC, Jr, Smith KR, Jr, Odom GL, Crafts DC, Giangaspero F (1983). Computerized tomographic and pathologic studies of the untreated, quiscent, and recurrent glioblastoma multiforme. J Neurosurg 58, 159-169. (Pubitemid 13190247)
8. Burger PC, Kleihues P (1989). Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies. Cancer 63, 2014-2023. (Pubitemid 19118906)
9. Cancer Genome Atlas Research Network (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068.
10. Cancer Genome Atlas Research Network (2010). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068.
11. Camby I et al. (1999). Supranatorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytoma and glioblastoma are characterized by a differential expression of S100 proteins. Brain Pathol 9, 1-19. (Pubitemid 29056515)
12. de Groot JF, Gilbert MR (2007). New molecular targets in malignant gliomas. Curr Opin Neurol 20, 712-718.
13. De Lozanne A, Spudich JA (1987). Disruption of the Dictyostelium myosin heavy chain gene by homologous recombination. Science 236, 1086-1091. (Pubitemid 17113250)
14. Dulyaninova NG, House RP, Betapudi V, Bresnick AR (2007). Myosin-IIA heavy-chain phosphorylation regulates the motility of MDA-MB-231 carcinoma cells. Mol Biol Cell 18, 3144-3155. (Pubitemid 47235318)
15. El-Obeid A, Bongcam-Rudoff E, Sorby M, Ostman A, Niser M, Westermark B (1997). Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in situ. Cancer Res 57, 5598-5604. (Pubitemid 28006770)
16. Gaiano N, Kohtz JD, Turnbull DH, Fishell G (1999). A method for rapid gain-of-function studies in the mouse embryonic nervous system. Nat Neurosci 9, 812-819. (Pubitemid 30491174)
17. Giese A, Westphal M (1996). Glioma invasion in the central nervous system. Neurosurgery 39, 235-250; discussion 250-252.
18. Grzimil M, Hemmings BA (2010). Deregulated signaling networks in human brain tumours. Biochim Biophys Acta 1804, 476-483.
19. Hoelzinger DB, Demuth T, Berens ME (2007). Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99, 1583-1593. (Pubitemid 351767231)
20. Ivkovic S, Canoll P, Goldman JE (2008). Constitutive EGFR signaling in oligodendrocyte progenitors leads to diffuse hyperplasia in postnatal white matter. J Neurosci 28, 914-922. (Pubitemid 351159001)
21. Kakita A, Goldman JE (1999). Patterns and dynamics of SVZ cell migration in the postnatal forebrain: monitoring living progenitors in slice preparations. Neuron 23, 461-472. (Pubitemid 29359918)
22. Kim HD, Guo TW, Wu AP, Wells A, Gertler FB, Lauffenburger DA (2008). Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence. Mol Biol Cell 19, 4249-4259.
23. Kong L, Deng Z, Shen H, Zhang Y (2010). Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phos-pho-Src-Y416 and phospho-EGFR-Y1173. Mol Cell Biochem 348, 11-19.
24. LeDuc Q, Shi Q, Blonk I, Sonnenberg A, Wang N, Leckbanbd D, deRooij J (2010). Vinculin potentiates E-cadherin mechanosensing and is recruited to actin-anchored sites within adherens junctions in a myosin II - dependent manner. J Cell Biol 189, 1107-1115.
25. Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS (2007). Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 9, 424-429.
26. Limouze J, Straight AF, Mitchison T, Sellers JR (2004). Specificity of blebbistatin, an inhibitor of myosin II. J Muscle Res Cell Motil 25, 337-341. (Pubitemid 40941093)
27. Lund CV, Nguyen MT, Owens GC, Pakchoian AJ, Shaterian A, Kruse CA, Eliceiri BP (2006). Reduced glioma infiltration in Src-deficient mice. J Neurooncol 78, 19-29. (Pubitemid 43786654)
28. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (2001). Malignant glioma: genetics and biology of a grave matter. Genes Dev 15, 1311-1333. (Pubitemid 32524640)
29. Malashkevich VN, Dulyaninova NG, Ramagopal UA, Liriano MA, Varney KM, Knight D, Brenowitz M, Weber DJ, Almo SC, Bresnick AR (2010). Phenothiazines inhibit S100A4 function by inducing protein oligomerization. Proc Natl Acad Sci USA 107, 8605-8610.
30. Manning TJ, Jr, Rosenfeld SS, Sontheimer H (1998). Lysophosphatidic acid stimulates actomyosin contraction in astrocytes. J Neurosci Res 53, 343-352. (Pubitemid 28350397)
31. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A (2002). Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 105, 1545-1547. (Pubitemid 34297629)
32. Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A (2003). Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 41, 15-19. (Pubitemid 36044397)
33. Mott RT, Turner KC, Bigner DD, McLendon RE (2008). Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytome. Laboratory investigation. J Neurosurg 108, 330-335. (Pubitemid 351213298)
34. Nagane M, Coufai F, Lin H, Bogler O, Cavanee WK, Huang HJ (1996). A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 27, 25639-25645.
35. Norden AD, et al. (2008). Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology 70, 779-787.
36. Okada Y, Hurwitz EE, Esposito JM, Brower MA, Nutt CL, Louis DN (2003). Selection pressure of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res 63, 413-416. (Pubitemid 36152501)
37. Panopoulos A, Howell M, Fotedar R, Margolis RL (2011). Glioblastoma motility occurs in the absence of actin polymer. Mol Biol Cell 22, 2212-2220.
38. Parsons DW et al. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1807-1812.
39. Reardon DA et al. (2008). Randomized phase II study of cilengitide, and integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. J Clin Oncol 26, 5610-5617.
40. Ren ZP, Olofsson T, Qu M, Hesselager G, Soussi T, Kalimo H, Smits A, Nister M (2007). Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors. J Neuropathol Exp Neurol 66, 944-954. (Pubitemid 47530833)
41. Salhia B, Frederieke Rutten F, Mitsutoshi Nakada M, Beaudry C, Berens M, Allison Kwan A, Rutka JT (2005). Inhibition of rho-kinase affects astrocytoma morphology, motility, and invasion through activation of rac1. Cancer Res 65, 8792-8800. (Pubitemid 41377367)
42. Scherer H (1940). Cerebral astrocytomas and their derivatives. Am J Cancer 1, 159-198.
43. Sen S, Dong M, Kumar S (2009). Isoform specific contributions of α actinin to glioma cell mechanobiology. PLoS One 4, e8427.
44. Shimokawa H (2002). Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 39, 319-327.
45. Shimokawa H, et al. (2002). Anti-anginal effects of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol 40, 751-761. (Pubitemid 36109293)
46. Stokes CL, Lauffenburger DA, Williams SK (1991). Migration of individual microvessel endothelial cells: stochastic model and parameter measurement. J Cell Sci 99, 419-430. (Pubitemid 21925029)
47. Stommel JM, et al. (2007). Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 318, 287-290. (Pubitemid 47574858)
48. Strawn LM, Mann E, Elliger SS, Chu ML, Germain LL, Niederfellner G, Ulrich A, Shawver LK (1994). Inhibition of glioma cell growth by a truncated platelet-derived growth factor-â receptor. J Biol Chem 269, 21215-21222. (Pubitemid 24266496)
49. Stupp R, Hegi ME, Gilbert MR, Chakravarti A (2007). Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol 25, 4127-4136. (Pubitemid 47492957)
50. Suemizu H, Monnai M, Ohnishi Y, Ito M, Tamaoki N, Nakamura M (2007). Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/ãcnull (NOG) mice. Int J Oncol 31, 741-751.
51. Sun Y, Goderie SK, Temple S (2005). Asymmetric distribution of EGFR receptor during mitosis generates diverse CNS progenitor cells. Neuron 45, 873-886. (Pubitemid 40395266)
52. Svitkina TM, Verkhovsky AB, McQuade KM, Borisy GG (1997). Analysis of actin-myosin II system in fish epidermal keratocytes: mechanism of cell body translocation. J Cell Biol 139, 397-415. (Pubitemid 27459313)
53. Thorne RG, Nicholson C (2006). In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc Nat Acad Sci USA 103, 5567-5572.
54. Ulrich TA, de Juan Pardo EM, Kumar S (2009). The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res 69, 4167-4174.
55. Ying H, Biroc SL, Li WW, Alicke B, Xuan JA, Pagila R, Ohashi Y, Okada T, Kamata Y, Dinter H (2006). The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models. Mol Cancer Ther 5, 2158-2164. (Pubitemid 44530451)
56. Wolburg H, Noell S, Mack A, Wolburg-Buchholz K, Fallier-Becker P (2009). Brain endothelial cells and the glio-vascular complex. Cell Tissue Res 335, 75-96.
57. Wullich B, Sattler HP, Fischer U, Meese E (1994). Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Anticancer Res 14, 577-579. (Pubitemid 24176807)